EUVIMEDEUVIMED entdecken
Crossref

Progression and Relapse of Pediatric Soft Tissue Sarcoma: Individualized Approach of Treatment – Experience from a Major Pediatric Cancer Center in Europe

Anke Elisabeth Barnbrock, Marie Luckowitsch, Stanislaw Schmidt, Constanze Buus-Gehrig, Leila Koscher, Martina Becker, Christian Vokuhl, Thomas Klingebiel, Thomas Lehrnbecher, Konrad Bochennek

Klinische Pädiatrie · 01.11.2023 · 235 (06) · 360-365

DOI: 10.1055/a-2103-2781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.11.2023. Verfasst von Anke Elisabeth Barnbrock und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology, Hospital of the Goethe University Frankfurt Centre for Paediatrics and Adolescent Medicine, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Sarcoma. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundThe outcome of children with refractory or relapsed soft tissue sarcoma (STS) is extremely poor. Whereas larger clinical trials evaluated specific treatment modalities, real-life data on individual multimodal therapeutic strategies, given alone or in combination, are scarce. Patients and Methods We retrospectively analyzed the clinical course of 18 pediatric patients with progression of or relapsed STS treated between 2008 and 2018 in our institution. Results A total of 18 patients (median age 12.4 years) suffered from progression or relapse of alveolar (n=7), embryonal (n=5), undifferentiated (n=2) rhabdomyosarcoma or desmoplastic small round cell tumor (n=4). 14 patents had an initial stage IV disease. All but one patient died. Median survival was 12.5 months. Shortest survival was seen in patients with systemic progression of the disease, longest in patients with local relapse. Patients with an Oberlin score

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsSarcomaHumansChildRetrospective StudiesNeoplasm Recurrence, LocalPrognosisChronic DiseaseDisease Progression

Autor:innen und Institutionen

  • Pediatric Oncology, Hospital of the Goethe University Frankfurt Centre for Paediatrics and Adolescent Medicine, Frankfurt am Main, Germany.
  • Department of Pathology, Section Pediatric Pathology, University Bonn, Germany.

Zitieren

APA

Barnbrock, A. E., Luckowitsch, M., Schmidt, S., Buus-Gehrig, C., Koscher, L., Becker, M., Vokuhl, C., Klingebiel, T., Lehrnbecher, T., & Bochennek, K. (2023). Progression and Relapse of Pediatric Soft Tissue Sarcoma: Individualized Approach of Treatment – Experience from a Major Pediatric Cancer Center in Europe. Klinische Pädiatrie, 235(06), 360-365. https://doi.org/10.1055/a-2103-2781

Vancouver

Barnbrock AE, Luckowitsch M, Schmidt S, Buus-Gehrig C, Koscher L, Becker M, et al. Progression and Relapse of Pediatric Soft Tissue Sarcoma: Individualized Approach of Treatment – Experience from a Major Pediatric Cancer Center in Europe. Klinische Pädiatrie. 2023;235(06):360-365. doi:10.1055/a-2103-2781

BibTeX
@article{Barnbrock2023,
  author = {Barnbrock, Anke Elisabeth and Luckowitsch, Marie and Schmidt, Stanislaw and Buus-Gehrig, Constanze and Koscher, Leila and Becker, Martina and Vokuhl, Christian and Klingebiel, Thomas and Lehrnbecher, Thomas and Bochennek, Konrad},
  title = {Progression and Relapse of Pediatric Soft Tissue Sarcoma: Individualized Approach of Treatment – Experience from a Major Pediatric Cancer Center in Europe},
  journal = {Klinische Pädiatrie},
  year = {2023},
  volume = {235},
  number = {06},
  pages = {360--365},
  doi = {10.1055/a-2103-2781}
}
Kostenlos starten →